Ligand profile
ZINC4611593
Virtual-screening candidate from ZINC.
Bound to: HT085_RS00215 — oligoribonuclease
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC4611593- UniProt (similar protein)
Q47VZ4- Tanimoto
- 0.559
- Target protein
- HT085_RS00215
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 127.7
- −1 ≤ LogP ≤ 5 0.21
- MW ≤ 500 Da 396.4
- LogP ≤ 5 0.21
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 127.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1ccc(S(=O)(=O)OC[C@H]2O[C@@H](n3cc(C)c(=O)[nH]c3=O)C[C@@H]2O)cc1Cc1ccc(S(=O)(=O)OC[C@H]2O[C@@H](n3cc(C)c(=O)[nH]c3=O)C[C@@H]2O)cc1
InChI=1S/C17H20N2O7S/c1-10-3-5-12(6-4-10)27(23,24)25-9-14-13(20)7-15(26-14)19-8-11(2)16(21)18-17(19)22/h3-6,8,13-15,20H,7,9H2,1-2H3,(H,18,21,22)/t13-,14+,15+/m0/s1InChI=1S/C17H20N2O7S/c1-10-3-5-12(6-4-10)27(23,24)25-9-14-13(20)7-15(26-14)19-8-11(2)16(21)18-17(19)22/h3-6,8,13-15,20H,7,9H2,1-2H3,(H,18,21,22)/t13-,14+,15+/m0/s1
RSEWNGNFIIXLHN-RRFJBIMHSA-NRSEWNGNFIIXLHN-RRFJBIMHSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 9RC
- Homolog
- Q47VZ4
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC4611593 →
- ZINC ZINC20 ZINC4611593 →
- UniProt UniProt Q47VZ4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC4611593”) →
Other ligands for this protein
Quick navigation to other ligands bound to HT085_RS00215.
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).